Preclinical studies have shown that GLP-1RAs influence essential signaling pathways, including the activation of farnesoid X receptor (FXR) and liver X receptor (LXR), which are crucial in lipid metabolism and inflammation (Errafii et al., 2022)
Dapagliflozin and Liraglutide Therapies Rapidly Enhanced Bone Material Properties and Matrix Biomechanics at Bone Formation Site in a Type 2 Diabetic Mouse Model
Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same
Understanding the root causes and available treatment options can empower women to manage these side effects effectively while pursuing their weight loss goals
According to NICE guidance (NG28), GLP-1 receptor agonists are recommended as treatment options for type 2 diabetes when certain criteria are met
And while some of these ingredients have modest evidence for metabolic benefits when taken orally, the evidence for skin absorption is essentially nonexistent